OPN contributes to the malignancy of cancer through the promotion of metastasis, maintenance of a stem-like phenotype, epithelial to mesenchymal transformation, activation of cell proliferation pathways, chemotherapeutic and radiation resistance, and interference with immune functioning. Here, SPP1 is linked to cancer.